Gilead’s Remdesivir Most ‘Beneficial’ In Covid-19 Patients Who Need Extra Oxygen, Study Shows

Gilead’s Remdesivir Most ‘Beneficial’ In Covid-19 Patients Who Need Extra Oxygen, Study Shows

Gilead Sciences Inc.’s (GILD) remdesivir, its coronavirus drug candidate, is most “beneficial” for Covid-19 patients who require supplemental oxygen but don’t need mechanical ventilation, according to a study by the National Institute of Allergy and Infectious Diseases (NIAID)."Ultimately, the findings support remdesivir as the standard therapy for patients hospitalized with Covid-19 and requiring supplemental oxygen therapy," the report said, citing preliminary results from the randomized, controlled trial, published in The New England Journal of Medicine.Over a 10-day course, patients received the antiviral remdesivir intravenously and a placebo. The report showed that patients who received remdesivir had a shorter time to recovery than those who received placebo. The median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo.“These findings support the use of remdesivir in this population, with the largest benefit observed among individuals who required oxygen supplementation but were not...

China's US$941 billion sovereign fund seeks more resilient assets to improve on 17 per cent gain in 2019

China Investment Corp (CIC) is looking for more resilient assets in markets battered by the coronavirus pandemic as the nation's US$941 billion sovereign wealth fund seeks to boost long-term returns, Executive Vice President Zhao Haiying said.The company added to its investments in credit markets in recent months, especially investment-grade loans in the US, after the Federal Reserve eased a liquidity crunch, Zhao said in an interview on Saturday. It added health care and information technology stocks and raised exposure in regions like Asia where there was "less uncertainty" about the spread of the virus, she said.Its overseas investments returned about 17 per cent last year based on unaudited results, she said, as global stocks rallied. That comes close to a record 17.6 per cent gain in 2017 and reverses a loss in 2018 when equities tumbled.Beijing-based CIC is fine-tuning its investment strategies. It sees a diversified portfolio as the best way...

Tesla Asks China To Build Model 3 Cars With LFP Batteries – Report

Tesla Inc. (TSLA) is asking the Chinese government for approval to build model 3 vehicles in the country equipped with lithium iron phosphate (LFP) batteries, Reuters reported.The name of the battery maker wasn’t disclosed, according to a document by the Ministry of Industry and Information Technology seen by Reuters.Reuters exclusively reported in February that Tesla is in advanced talks to use LFP batteries from CATL that contain no cobalt - one of the most expensive metals in electric vehicle (EV) batteries - in cars made at its China plant.Tesla did not immediately respond to a request for comment from Reuters.Model 3 vehicles are being built at the U.S. car maker’s Shanghai factory. On May 8 Tesla revealed that it secured a 4 billion yuan ($565M) lending line for continued expansion of production at the Gigafactory Shanghai.The company uses EV batteries from Panasonic Corp and LG Chem. CATL has said it would...